Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oramed Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Oramed Pharmaceuticals

Oramed Pharmaceuticals

Public

Israel-based Oramed Pharmaceuticals, Inc. develops oral insulin capsules and drug delivery solutions.

HQ
New York City, NY, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Oramed Pharmaceuticals, Inc., founded in 2006 and headquartered in Jerusalem, is a biotech company specializing in the development of oral drug delivery systems. Their flagship product is an oral insulin capsule aimed at treating type 2 diabetes. The company also focuses on creating delivery solutions for other drugs and vaccines, striving to revolutionize the way medications are administered and improving patient compliance and outcomes.

Oramed has achieved significant milestones, including being publicly traded on Nasdaq (ORMP) and the Tel Aviv Stock Exchange (ORMP). The company is a component of the Russell Microcap Index. Notable achievements include a joint venture with HTIT to advance oral drug delivery technology globally and a distribution contract with Medicox for South Korea. CEO Nadav Kidron leads the company, which continues to make strides in the biotech industry.

Oramed Pharmaceuticals - Similar Companies

Diasome Pharmaceuticals logo

Diasome Pharmaceuticals

diasome.com

Insulet logo

Insulet

insulet.com

Htbt logo

Htbt

Orcosa logo

Orcosa

orcosa.com

NovaDel Pharma logo

NovaDel Pharma

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Assertio Holdings logo

Assertio Holdings

Oryza Pharmaceuticals logo

Oryza Pharmaceuticals

oryzapharma.com

OrphoMed logo

OrphoMed

Galmed Pharmaceuticals logo

Galmed Pharmaceuticals

galmedpharma.com

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Generex Biotechnology logo

Generex Biotechnology

generex.com

Omeros logo

Omeros

omeros.com

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

biocryst.com

Orpro Therapeutics logo

Orpro Therapeutics

Oramed Pharmaceuticals - Quick Facts

Who are Oramed Pharmaceuticals' competitors?

Companies similar to Oramed Pharmaceuticals include Diasome Pharmaceuticals, Insulet, Htbt and Orcosa.

When was Oramed Pharmaceuticals founded?

Oramed Pharmaceuticals was founded in 2006.

Where is Oramed Pharmaceuticals' headquarters located?

Oramed Pharmaceuticals' headquarters is located in New York City, NY, US.

When was Oramed Pharmaceuticals' last funding round?

Oramed Pharmaceuticals' most recent funding round was for $101.9M (USD) in September 2023.

How much has Oramed Pharmaceuticals raised to-date?

As of Sep 21, 2023, Oramed Pharmaceuticals has raised a total of $236.6M (USD).

How many employees does Oramed Pharmaceuticals have?

Oramed Pharmaceuticals has 13 employees as of Feb 6, 2024.

Oramed Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
  • Insulin
Tags
  • Healthcare
  • Pharma
Unique IDs
  • ein: 980376008
  • secCik: 0001176309
  • ticker: ORMP
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 1400Mining And Quarrying Of Nonmetallic Minerals, Except Fuels
  • 2000Food And Kindred Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research